Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome - MesaCAPP

NCT03070574 is registered in ClinicalTrials.gov with Christoph Gasche as lead sponsor.

NCT NCT03070574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03070574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome - MesaCAPP
Lead sponsor
Christoph Gasche
Phase
Phase 2
Overall status
Terminated
Start date
November 24, 2017
Completion date
April 10, 2019
Enrollment
8 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer